The effect of insulin-like growth factors (IGFs) and insulin on the release of progesterone and oxytocin from bovine corpus luteum was investigated at early (days 5\p=n-\7), mid-(days 8\p=n-\12) and late (days 15\p=n-\18) luteal phases of the oestrous cycle in an in vitro microdialysis system. The expression of specific receptors was evaluated in bovine corpora lutea of the respective luteal stages.
Introduction
Insulin-like growth factor 1 (IGF-1) is a basic peptide of 70 amino acids which stimulates a variety of biological processes (Rinderknecht & Humbel, 1978) . The granulosa cells are sites of its produc¬ tion (Hammond et al., 1985; , reception (Veldhuis et ai, 1985; Adashi et al., 1986) and action (Savion et al., 1981; Adashi et al., 1984; Davoren et al., 1985; Schams et al., 1987) . Bovine corpus luteum was also defined as a site of IGF-1 mRNA expression, peptide production and its action (Einspanier et al., 1990) . Both chronic and acute stimulation of the two major hormone products of bovine corpus luteum, progesterone and oxytocin by IGF-1 led to speculation that IGF-1 may be an autocrine/paracrine factor in cows (McArdle & Holtorf, 1989; Einspanier et al., 1990) . If this hypothesis is correct there must be binding sites of IGF-1 in bovine corpora lutea (for review see Rechler, 1988) .
The aim of this study was to demonstrate and characterize the binding sites for IGF-1 in bovine luteal tissue. The binding and effects of the related peptides, IGF-2 and insulin, were also investigated. Since expression of IGF-1 mRNA and production of IGF-1 peptide paralleled each other and their activity changed during the oestrous cycle (Einspanier et al., 1990) , we investigated how binding of growth factors is related to stimulation of progesterone and oxytocin during the oestrous cycle in cows.
Materials and Methods

Collection of corpora lutea
The corpora lutea from German Fleckvieh cows were collected from a local slaughterhouse within 10-20 min of slaughter. The stage of the cycle was defined by macroscopic observation of the ovaries (follicles and corpora lutea) and the uterus (size, colour, consistency, connective tissue and mucus). The corpora lutea were assigned to stages of the luteal phase, days 5-7, days 8-12 and days 15-18 after ovulation. Corpora lutea from 114 cows were used for all the experiments presented herein. For the in vitro perfusion study, the corpora lutea were washed with saline at 38°C several times, and transported to the laboratory in Medium 199 (Sigma, Munich, Germany) at pH 7-2, 38°C containing lOmmol NaHCO, 1', Earle's salts, L-glutamine, 25 mmol Hepes l_l, 0-5% (w/v) bovine serum albumin, 60 mg penicillin 1 ', 100 mg streptomycin 1 ', 2 mg amphotericin 1 ' and 56 mg ascorbic acid 1 ' (M199). For the preparation of microsomal membranes, the corpora lutea were separated from the ovaries immediately, snap frozen in liquid nitrogen and were then stored at -80°C until processed.
Microdialysis perfusion system in vitro
The microdialysis perfusion system of Jarry el al. (1987) was used with modifications for the in vitro organ culture described in detail by Miyamoto & Schams (1991) . All manipulations were conducted at 38°C in M199. Each corpus luteum was cut to a 10-12 mm cube, and bisected through the face of the apex (days 8-12 and 15-18) or used without bisection (days 5-7). Each luteal piece was penetrated by an 8-10 mm dialysis capillary (Fresenius SPS 900 Hollow Fibers, Fresenius AG, St Wendel, Germany; cut off Mr 100 kDa, 0-2 mm diameter). The capillary was attached with each end to Silastic tubing (i.d. 0-3 mm) by glue. The tubing was fixed on the face of the luteal piece by Histoacryl blue (B. Braun-Dexon GmbH, Spangenberg, Germany) to hold the dialysis capillary in the luteal tissue. For the perfusion one of the tubes was connected to a peristaltic pump, and the other was joined to the fraction collector. The luteal pieces prepared in this way were maintained in organ culture chambers (2070 Tube, Falcon, USA) filled with 50 ml M199 at 38°C in a water bath. M199 was continuously exchanged at a flow rate of 15 ml h '. The luteal pieces were perfused by Ringer's solution at a flow rate of I ml in 10 min for 8 h; in earlier experiments we demonstrated that the endocrine function of the pieces of corpus luteum, i.e. the progesterone release and its responsiveness to luteinizing hormone (LH) stimuli, is not adversely affected even after 7 h incubation (Miyamoto & Schams, 1991) . After 3 h preincubation, perfusate fractions were collected every 10 min for 5 h. Because of the great individual variation of the basal hormone concentrations between luteal pieces, the mean concentrations of the first six fractions ( 1 h perfusion) were used for calculating an individual progesterone baseline. For oxytocin the baseline was determined as the con¬ centration of the pooled first six fractions. All hormone concentrations in the fractions collected from each piece of corpus luteum were then expressed as a percentage of individual baseline (100%). IGF-1 and IGF-2 were dissolved in acetic acid (lOmmoll-1) to a concentration of lOmgml ' and were then diluted with water to I mg ml ' stock solutions. The IGF solutions were stored at -20"C. Insulin was dissolved in exactly the same way as IGFs just before the start of the experiment. All peptides were diluted with Ringer's solution to the final concentrations needed (for IGFs: range 10-1000 ng ml '.i.e. 1-3-130 nmoll '; forinsulin: 76-7600 ngml·' i.e. 13-1300 nmol 1'). The possibility that the pH of the infúsate may produce some artefact effect on the hormone release was excluded by running 1 µ 1 ' (for IGFs) or 7-6 µ 1 ' (for insulin) acetic acid in Ringer's solution in the controls parallel to the various treatments. Effluent fractions were stored at -20°C until assayed for progesterone and oxytocin. The diffusion capacity of the membrane for IGFs and insulin was about 01% of the concentration infused as determined in previous methodological experiments.
Progesterone and oxytocin determination
Concentrations of progesterone were determined directly in duplicate 20 µ samples of the perfusate fractions with an enzyme immunoassay in microtitre plates based on the double antibody technique of Prakash et al. (1987) . Progesterone-3-(0-carboxymethyl)oxime linked to peroxidase through a 6-aminocaproic acid spacer (Sigma, Munich, Germany) was applied as tracer; progesterone-1 la-hemisuccinate-BSA has been used for the production of the antibody that was characterized earlier (Hoffmann et ai, 1973) . The final antibody dilution was 1:500000. The standard curve ranged from 0-4 to lOOngml ' and the ED50 of the assay was lOngml '. The intraand interassay coefficients of variations were below 10-0%.
Oxytocin concentrations in the pooled fractions (fraction 1-6, 7-9 and 10-15) were directly quantified by radioimmunoassay (Schams, 1983) . The standard curves ranged from 0-625 to 80pgml ' and the ED5I1 of the assay was 14-2 pgml '. The intraand interassay coefficients of variation were 8-7% and 7-8%, respectively.
Membrane preparation
Corpora lutea were transferred into three volumes of lOmmol Tris 1 ', 250mmol sucrose 1 ', 1 mmol CaCl21"' pH 7-5 and were homogenized in an ice bath with Ultra Turrax equipment (Janke and Kunkel, Staufen, Germany). Five bursts of 15 s at maximum speed with 45 s intervals of cooling between each burst were used. From each cyclic stage three pools each consisting of 6 corpora lutea were prepared. The homogenate was subsequently centrifuged at 800 £ for 15 min at 4°C. The supernatant was collected and centrifuged at 100 000 g for 60min at 4°C. The pellet was resuspended in lOmmol Tris 1 ', 5 mmol CaCl, 1 ', 75 mmol NaCl 1~', pH7-5 and then repelleted. After washing twice, the final pellet was resuspended in the same buffer to a concentration of 250 mg original tissue weight per ml preparation. The preparation was aliquoted and stored at -30°C until assayed.
Radioreceptor assays
Recombinant human IGF-1 (Ciba, Basel, Switzerland), human IGF-2 (Ciba) and insulin (synthetic bovine insulin. Novo, Copenhagen, Denmark) were iodinated by a modified lactoperoxidase method (Thorell & Johansson, 1971 ) to specific activities of 40-60 µ µg~' . The receptor preparations were thawed at room temperature and were then added in brief succession to the test tubes containing l25I-labelled ligand and unlabelled IGF-1, IGF-2 or insulin. All reagents were prepared in 10 mmol Tris 1 ',5 mmol CaCl, 1 ', 75 mmol NaCl 1 ' pH 7-5, 0-5% (w/v) bovine serum albumin. The assays were performed in duplicate with membrane homogenates of 25 mg corpora lutea weight equivalents per tube containing approximately 300 µg protein as measured with the BCA method (Smith et ai, 1985) . Preliminary experiments have shown that the binding of the l:5I-labels is proportional to the amount of membrane preparation added in the range of membrane concentration used for the present studies. The optimal assay conditions for '"M-labelled IGF-1, '-'I-labelled IGF-2 and ,2SI-labelled insulin binding were first defined for further characterization of the binding sites. Maximum binding was obtained at 4°C after 4 h and remained stable for about 30 h. Because of these findings all subsequent binding experiments were performed at 4"C overnight.
Approximately 002 µ ,:5I-labelled ligand (IGF-1, IGF-2 or insulin) was incubated in the presence of 0-10000 ng unlabelled IGF-1, IGF-2 or insulin per tube for 16 h at 4"C. Equilibrium was reached under these conditions; no significant tracer degradation was observed during the incubation as determined by TCA precipitation (Banskota et al., 1986) . The incubation was terminated by addition of 2 ml ice cold lOmmol Tris 1 ', 5 mmol CaCl2 I"1, 75 mmol NaCl 1 ' pH 7-5; bound and free tracer were separated by centrifugation at 3000 # at 4°C for 30 min. The reproducibility of the receptor assays were estimated by linear regression analysis of repeated determinations of the binding characteristics. The association constant and the binding capacity Bmn of all receptor assays taken together showed excellent correlation (r = 0-990, slope 118 for and r = 0-873, slope 1-04 for 5m").
Statistical analysis
For the analysis of the microdialysis perfusion system stimulation experiments, the concentrations of progesterone (%) in the first six fractions from each experimental group were pooled to obtain baseline values. The peaks of progesterone or oxytocin release, and the areas under the curves of progesterone release (units in 4h) after the beginning of the 30 min stimulation by IGFs or insulin at different doses or at different luteal phases of the oestrous cycle were tested by analysis of variance and Duncan's new multiple range test, Student's / test or the Cochran-Cox test.
The data obtained on binding of IGF-1, IGF-2 and insulin to membranes of corpora lutea were analysed with the ligand programme (Munson & Rodbard, 1980) using nonlinear iterative curve-fitting procedures (McPherson, 1985) . The initial parameters were calculated by Scatchard analysis (Scatchard, 1949) and were then iteratively refined until the weighted sum of squares was minimized. The goodness of fit for the selected model was assayed by the 'runs test'. Different models (one or two binding sites) were compared using F test statistics to determine whether a change in the model resulted in a significant reduction in the weighted sum of squares. The criteria for rejecting or accepting a particular model were based on the calculated probability values (Munson & Rodbard, 1980) . The final parameter estimates obtained from three pools of three different stages of the cycle were analysed by analysis of variance. The significance of differences between the different cyclic stages were then assessed by Student's t test using the Bonferroni correlation for multiple comparison. Data are expressed as means + sd.
Results
Effect of various doses of IGF-1, IGF-2 and insulin on the release of progesterone and oxytocin from luteal tissue A 30 min perfusion with IGF-1, IGF-2 (1-3-130 nmol ') or insulin (13-1300 nmol ') through corpora lutea from days 8 to 12 induced a significant peak of progesterone release (P < 005; Fig. 1 ). Comparing the total release of progesterone during 4h after the beginning of stimulation with the different peptides (i.e. the areas under the curves) the stimulation of progesterone release by IGF-1 was greater than that produced by IGF-2 or insulin ( < 005; Table 1 ).
In contrast to the progesterone stimulation, higher IGF concentrations (130 nmol 1~') were needed to stimulate oxytocin release (146-3 ± 10-3% for IGF-1 and 1391 ± 4-9% for IGF-2, respectively, < 005). Insulin showed a semi-dose-dependent effect on oxytocin release (131-6 ±10-5% for 13 nmol l"1, 1420+131% for 130 nmol ' and 329-8 + 47-8% for 1300 nmol 1 '; < 005).
Effect of IGF-1, IGF-2 and insulin on the release of progesterone and oxytocin from luteal tissue at different stages of the luteal phase IGF-1 (130 nmol I-1), IGF-2 (130 nmol 1) or insulin (1300 nmol 1) stimulated the release of progesterone throughout the luteal phase (P < 005; Fig. 2 ). All three substances stimulated the peak height of progesterone release during the late luteal phase (days 15-18; < 005). Additionally, the effect of IGF-1 on the total release of progesterone (units in 4 h) was greatest after the beginning of the stimulation during this stage (P < 005; Table 2 ).
All three peptides stimulated the release of oxytocin throughout the luteal phases (P < 005; Fig. 3 ). Insulin was more effective at early to mid-luteal stages than at late luteal phase (P < 005).
Competition of binding to IGF-1 and IGF-2 receptors l25I-labelled IGF-1 binding was displaced in a dose-dependent manner by unlabelled IGF-1 (Fig. 4 ). About 80% of l25I-labelled IGF-1 bound to membranes of corpora lutea could be displaced by the highest concentration of unlabelled IGF-1 indicating that nonspecific binding contributed to about 20% of the total binding of IGF-1 to membranes of corpora lutea. IGF-2 was about five times less effective in displacing l25I-labelled IGF-1. Unlabelled insulin showed significant displacement only at concentrations higher than 2 µ 1 '.
Specific binding of l25I-labelled IGF-2 to bovine corpora lutea membranes was markedly higher than for l2T-labelled IGF-1 (39-4 ± 7-8% versus 20-8 ± 2-1 %). Nonspecific binding accounted for 27% of total binding. l25I-labelled IGF-2 was displaced by IGF-2 in a dose-dependent manner whereas IGF-1 and insulin exhibited negligible binding affinities. The specific binding of l25I-labelled insulin (80 ±11 %) was lower than that of 125I-labelled IGF-1 or l25I-labelled IGF-2.
The binding in the presence of the highest concentration of unlabelled insulin was 36% of total binding. 125I-labelled insulin was displaced by insulin in a dose-dependent manner. IGF-1 and IGF-2 showed comparable binding affinities.
Scatchard plots for the competitive binding of l25I-labelled IGF-1 and unlabelled IGF-1 were linear (Fig. 5 Fraction number (1 ml in 10 min/per fraction) Fig. 1 . Dose-dependent release of progesterone by (a) insulin-like growth factor (IGF)-l, (b) IGF-2 and (c) insulin from microdialysed bovine corpora lutea in vitro (days 8-12 of the oestrous cycle). All values are shown as percentage of the respective baselines (mean + sem; = 5 corpora lutea per group) that were calculated from the first six fractions (perfused with Ringer's solution only). The filled bars indicate the peptide application. Absolute concentrations of progesterone from baselines were 7-31 ± 0-28 ngml"1 (n -60, mean + sem).
1-53
10'± 7-65 107mol_ ' 1, ßmax = 2-07 10 ± 5-38 10l2mol 1). In comparison the Scatchard plots of specific IGF-2 binding (Fig. 6 ) had a markedly higher capacity (Bmnx = 2-18 10 9± 1-29 10-'°moir'); the affinity was lower (Ä, = 3-49 IO8 + 4-78 107moF'l). Scatchard analysis of the insulin binding data showed curvilinear plots (Fig. 5) . A two-site model was superior for describing the binding characteristics as demonstrated with the ligand program. The affinity constant and the capacity of the high affinity binding site were Kai = 115 109 + 2-80 108mor'l and Bmax] = 6-70 10"" ± 1-49 10"" moll"1. For the low affinity site the K.^w as calculated as 1-86 107 + 7-05 106moF'l and the 5max2 as 1-08 10~9 + 2-49 lO^moir1. IGF-I 2468 ± 51 2843+179 3185 ± 133***" 3123 ± 65***" IGF-2 2457 ±28 2726+ 65** 2666+ 98" 2719 + 89*" Insulin 2409 + 49 2697+165" 2769 + 58**" 3144+163* *P < 005, **P < 001 and ***P < 0001 versus control.
""Values with different superscripts in each column differ ( < 005).
IGF-1 and IGF-2 binding to membranes of corpora lutea during the oestrous cycle The characteristics of the binding of IGF-1, i.e. and 5max, to membranes of corpora lutea prepared from early (days 5-7), mid-(days 8-12) and late (days 15-18) luteal stages showed no difference when expressed on a per gram original wet weight basis. Displacement studies of l25I-labelled IGF-1 with unlabelled IGF-1, IGF-2 and insulin showed the same relative affinities during early and late luteal phase as demonstrated above for the mid-luteal phase (Fig. 5 ). How¬ ever, significantly less protein was extracted from corpora lutea of the early luteal phase compared with the midand late phases which yielded identical protein concentrations in the membrane preparations. In the late luteal phase unlabelled IGF-2 at low concentrations (01-10 ng per tube) augmented 125I-labelled IGF-2 binding as much as 40% over that observed in the absence of unlabelled hormone (Fig. 6 ). This augmentation of binding was minimal or absent in early and mid-luteal phase corpora lutea. No cycle dependent difference was seen in the negligible binding of IGF-1 and insulin to IGF-2 binding sites. Insulin binding characteristics showed no difference in Kal,
, £max] and ¿?max2 between days 5 and 7 and days 8 and 12. High-affinity sites could not be detected in corpora lutea membranes from days 15-18. There was no cycle dependent difference in the affinity of IGF-2 to ,25I-labelled insulin binding sites. For IGF-1 a relatively higher affinity for insulin binding sites was observed during midand late luteal phases when compared with the early stages.
Discussion
In addition to the well-documented effects of IGFs and of insulin on mitogenesis and cell differen¬ tiation of bovine granulosa cells (Savion et ai, 1981) , our study provides further evidence for stimulation by these peptides of secretory processes in bovine luteal tissue. IGFs and insulin stimulated the release of progesterone and oxytocin in the microdialysis perfusion system. Although the mechanism of this acute release of hormones is not clear, comparable acute intracellular events have previously been demonstrated in different systems, e.g. in cultured porcine thyroid cells a very rapid effect (within 1-2 min) of IGF-1 on cytoplasmic pH has been described (Takasu et al., 1990) ; in mouse adipose tissue an activating effect of insulin on phosphatidylinositol phospholipase C was evident within 5 min (Chou et al., 1990) . The acute stimulation of hormone release in our experiments therefore appears as a physiological response of luteal tissue that is possibly based on similar intracellular effects. The question of whether the increased progesterone release results from stimulation of steroid synthesis or whether it reflects an increased release of already synthesized progesterone remains open. The increased baseline that is seen under IGF-1 stimulation might support the concept of an effect on steroidogenesis itself. IGF-1 was the effective factor in stimulating the release of progesterone in the microdialysis perfusion system. The predominant feature of the IGF-1 effect was a gradual increase in progesterone release after the first peak that was directly related to the peptide infusion. In consequence the total release of Fraction number (1 ml in 10 min/per fraction) Fig. 2 . Effect of intraluteal application of (a) insulin-like growth factor (IGF)-l (130 nmol 1"'), (b) IGF-2 (130 nmol ') and (c) insulin (1300 nmol l-1) on the release of progesterone at differ¬ ent stages of the luteal phase in vitro (mean + sem; = 5 corpora lutea per group). The filled bars indicate the peptide application. Absolute concentrations of progesterone from baseline varied with luteal phase from 9-95 + 1 -33 ng ml-' for days 5-7 and 7-66 + 0-56 ngmF' for days 8-12 to 4-35 + 0-56 ng 1 for days 15-18 of the oestrous cycle (n = 15 for each group; mean + sem). progesterone after stimulation was increased. In contrast, IGF-2 or insulin at the same dose as IGF-1 caused an acute release of progesterone that was limited to the time of the peptide infusion. This might suggest a different mode of action for IGF-1 and IGF-2 or insulin, that is possibly mediated by different types of receptor. Indeed, we found different types of receptor in the bovine luteal tissue. The presence and the typical binding characteristics of the type 1 IGF receptor (preferential binding of IGF-1, lower affinity for IGF-2 and binding of insulin only at much higher concentrations) was evident at all luteal stages. Additionally, type 2 IGF receptors were present throughout the luteal cycle. Although we found about twofold higher specific binding of IGF-2 compared with IGF-1, the limited significance of quantitative comparisons of different receptor Table 2 . Comparison of the areas under the curves of progesterone release (units in 4 h) after the beginning of the stimulation for 30 min with insulin-like growth factor (IGF)-l, IGF-2 or insulin in the luteal tissue of cows at three different luteal stages (« = 5; mean + sem) 1-6 7-9 10-15 1-6 7-9 10-15 Fig. 3 . Effect of intraluteal application of (a) insulin-like growth factor (IGF)-1 (130 nmol 1_1), (b) IGF-2 (130nmoll_1) and (c) insulin (1300 nmol l-1) on the release of oxytocin at different stages of the luteal phase in vitro (means ± sem; = 5 corpora lutea per group). (D) values from pooled baselines (fractions 1-6), ( ) during peptide infusion (fraction 7-9) and (El) after peptide infusion (fractions 10-15), respectively. Absolute oxytocin concentrations changed with the luteal stages from 71-2 + 19-7 pgmF1 for days 5-7 and 48-7 ± 21-lpgmF' for days 8-12 to 1-4 + 0-2pgmr' for days 15-18 of the oestrous cycle (n = 15 for each group; mean ± sem). *P < 0-05 compared with the respective baseline values (100%). types must be considered; even if there was no difference in the specific activities of IGF-1 and IGF-2 tracers as in our studies, there might be differences in the amount of tracer available for receptor binding. Competitive binding of (a) l25I-labelled insulin-like growth factor (IGF)-l, (b) 125Ilabelled IGF-2, (c) l25I-labelled insulin and (A) unlabelled IGF-1, (·) IGF-2 and ( ) insulin to membrane preparations of bovine corpus luteum at days 8-12 of the oestrous cycle.
In the insulin binding experiments, we observed the characteristic two-site binding model with affinity constants that were in the same range as reported previously for insulin receptors (Hollenberg & Cuatrecasas, 1975) . However, the relative potencies of unlabelled IGF-1 and IGF-2 in displacing the insulin tracer did not show the characteristic rank of order (insulin > IGF-1 > IGF-2) that has been described as typical for insulin receptors. Instead, all three unlabelled ligands showed similar potencies. It remains unclear whether the specific insulin binding in bovine luteal tissue is due to insulin receptors or whether type 1 IGF receptors account for this. Insulin receptors have been demonstrated in bovine granulosa cells (McArdle et al., 1991) and this obser¬ vation might support the presence of these receptors in luteal tissue. However, this issue cannot be resolved by binding studies; possibly the use of selective antibodies that are validated for bovine samples would be a useful way to resolve this question. Considering our receptor data and the stimulation experiments in the microdialysis perfusion system, the effects of IGF-1 on progesterone and oxytocin secretion are probably mediated via the specific type 1 receptor. An effect of IGF-1 mediated through insulin receptors should also be considered although the presence of insulin Fig. 5 . Representative Scatchard plots for the competitive binding of (A) ,25I-labellcd insulin¬ like growth factor (IGF)-l and unlabelled IGF-1, (·) of l25I-labelled IGF-2 and unlabelled IGF-2 and (D) for l25I-insulin and unlabelled insulin to membrane preparations of bovine corpus luteum at mid-luteal stage (days 8-12). receptors in the bovine corpus luteum is not yet clear. Compared with IGF-1, the mode for IGF-2 action seems to be more complex. There are three possible interpretations of our results. First, IGF-2 may mediate its effects on luteal secretion through the type 2 receptor (binds exclusively IGF-2, negligible binding of both IGF-1 and insulin). Second, IGF-2 could act on luteal secretion through the type 1 receptor, although the effects seem to be different from those of IGF-1. Finally, IGF-2 may act via insulin receptors provided that this receptor type is expressed in the bovine corpus luteum. With regard to the stimulation in the microdialysis perfusion system, IGF-2 was as effective as insulin in this study. When the effects of IGF-2 on progesterone release are compared with those of insulin in the dose-response experiment, 13 nmol 1 of both peptides showed very similar effects. This suggests that the action of IGF-2 could be mediated via insulin receptors, but it does not necessarily exclude the possibility that the type 2 receptor is dominantly concerned.
Insulin was also a very potent stimulator in our system. The data support the chronic effects of insulin in stimulating bovine luteal cells in long-term culture (McArdle & Holtorf, 1989 ). This group showed that the EC50 of insulin was only sevenfold higher than that for IGF-1, which is in agreement with our observations on the acute effects of these peptides. The existence of specific receptors for insulin in bovine corpora lutea is supported, since for type 1 IGF-receptor-mediated insulin responses a relatively higher insulin dose seems necessary to achieve the same reaction as that induced by IGF-1, which has a higher affinity for its receptor. The effects of IGFs and insulin on luteal secretion changed with luteal stages. All three peptides were most effective in stimulating the relative peak heights of progesterone release in the late luteal stage of the oestrous cycle, whereas an effect on the total release of progesterone was limited to IGF-1 stimulation. The observation that corpora lutea of late luteal stage show the highest response is noteworthy since at this stage the basal progesterone release is lower than at other luteal phases. Factors such as IGF-1 are possibly important in the late luteal phase to ensure luteal function. With regard to the increasing intraluteal IGF-1 concentrations (Einspanier et al., 1990 ) at this stage, it is possible that the role of IGF-1 is to maintain release of progesterone from corpora lutea that is sufficient for physiological function. However, the effects on oxytocin release showed a different profile: the IGFs tended to be less effective at the mid-luteal stage whereas insulin was most effective at early to mid-luteal stages. This observation supports the hypothesis that IGF-1 and insulin might act in different ways in luteal tissue.
The different effectiveness of IGF-1 in three luteal stages on luteal secretion cannot be attributed to differing type 1 receptor concentrations because there was no difference observed in either affinity or capacity of the IGF-1 receptor. Considering the endogenous luteal tissue IGF-1 concentrations (Einspanier et al., 1990) , which show a linear increase from days 1-5 until days 12-17, it is possible that the constant receptor population is saturated: taking 1 % of total IGF-1 as freely available IGF-1 as estimated for plasma (Baxter & Martin, 1986 ) as a basis, additional exogenous free IGF-1 is potentially more effective in early corpora lutea compared with mid-luteal corpora lutea according to the law of mass action. However, nothing is known about the distri¬ bution of IGF-1 in luteal tissue, i.e. about the ratio of free and bound IGF-1. Additionally, a possible shift in the ratio of the different binding proteins during the oestrous cycle might affect the amount of IGF-1 available for receptor binding.
The changing effects of IGF-2 on progesterone and oxytocin secretion of tissue of corpora lutea during the oestrous cycle might partly be explained by a change in the population of type 2 recep¬ tor. The observation that IGF-2 at low concentrations increases the specific binding of l25I-labelled IGF-2, as we found in corpora lutea at the late luteal phase, has been described previously in cell culture systems as well as in binding studies on isolated membranes (Marsh et ai, 1984; Barenton et ai, 1986) . It might be attributed to a positive co-operative interaction, that is intrinsic to the receptor and to its oligomeric structure as concluded by Marsh et al. (1984) . The possibility that binding proteins released by the cell might cause the described co-operativity (e.g. Barenton et ai, 1986 ) is unlikely because we used isolated membranes in our receptor studies. The positive cooperativity of IGF-2 binding to bovine corpora lutea membranes is also indicated by Scatchard plots (De Lean & Rodbard, 1979) ; this feature could be seen not only in the late luteal stage but also in mid-luteal phase corpora lutea (Fig. 6 ), although specific binding was not increased at low IGF-2 concentrations in this case. However, this phenomenon is probably only one factor influenc¬ ing the different action of IGF-2 in corpora lutea during the oestrous cycle. As discussed for IGF-1, the binding to related receptors, the presence of binding proteins as well as the endogenous concen¬ tration of the respective peptides are important but presently only partially known determinants for the effect of IGF-2.
In conclusion, the results of this study give further evidence that IGF-1 and related peptides may be important autocrine/paracrine regulators of the intraluteal function. The local expression of IGF-1 favours its role as the more important peptide. Further studies on the local production of IGF binding proteins, of IGF-2 and also of insulin receptors are needed to clarify the physiological role of the IGFs and insulin for the function of the corpus luteum.
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